Exclusive, clinically proven EPs 7630 extract with more than 20 clinical studies, including 9 prospective, randomized, double blind, parallel group, placebo-controlled clinical trials.
Shortens duration and reduces severity of upper respiratory tract irritations.
Studied in more than 9,000 patients + addresses the underlying cause of symptoms to help with recovery and duration of the common cold.
For over 35 years, patients and clinicians have trusted Integrative Therapeutics for our dedication to quality, potency, and accuracy. Transparency around our sourcing and manufacturing processes is part of our quality promise to you.
We ensure superior quality from safety documentation to facility audits; methodically testing of raw material lots to ensure purity and potency; and testing finished goods to make sure they meet our label and shelf-life expectations.
